Companies

MILESTONE SCIENTIFIC INC.

MLSS · CIK 0000855683 · operating

$0.28+11.82%Last updated Mar 3, 8:57 PM

Key Statistics

Valuation

Market Cap$22.13M
P/E
Fwd P/E-4.69
PEG
P/S2.48
P/B8.80
EV/EBITDA-3.31
EV/Rev2.45

Profitability

Gross Margin
Op. Margin
Net Margin
ROE-80.81%
ROA-48.11%
FCF Margin

Financial Health

Current Ratio2.48
Debt/Equity0.68
Free Cash Flow-$2.92M
Div. Yield

Growth & Other

Revenue Growth
EPS Growth
Beta0.94
52W High$1.12
52W Low$0.22

About MILESTONE SCIENTIFIC INC.

Milestone Scientific Inc. is a biomedical technology company that develops and commercializes computer-controlled injection and drug delivery systems for dental and medical applications. The company holds patents on technologies designed to enable precise, controlled delivery of anesthetics, medications, and other substances while reducing patient discomfort. Its product portfolio includes both single-use disposable handpieces and reusable delivery systems configured for specific clinical settings.

The company operates through two primary segments: Dental and Medical. In dentistry, Milestone Scientific markets the Wand and STA Single Tooth Anesthesia System under the CompuDent brand, which provide local anesthetic delivery for dental procedures. The CompuFlo platform represents the company's core computer-controlled delivery technology, available in configurations including CompuFlo Epidural for anesthesia applications and CompuMed for use across multiple medical specialties including orthopedics, dermatology, plastic surgery, podiatry, and colorectal procedures. The company also manufactures disposable injection handpieces designed for tactile control during drug administration.

Milestone Scientific operates at a modest scale with 17 full-time employees and is headquartered in Roseland, New Jersey. The company maintains a geographic footprint spanning the United States, China, and other international markets. As a publicly traded entity on the NYSE, the company remains engaged in manufacturing and distributing its specialized medical devices through existing distribution channels.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$-0.06+40.0%
2023$-0.10+16.7%
2022$-0.12-20.0%
2021$-0.10$-0.10+16.7%
2020$-0.12$-0.12+25.0%
2019$-0.16$-0.16+23.8%
2018$-0.21$-0.21-31.2%
2017$-0.16$-0.16+27.3%
2016$-0.22$-0.22+15.4%
2015$-0.26$-0.26-225.0%
2014$-0.08$-0.08-200.0%
2013$0.08$0.09
2012
2011

Annual Reports (10-K) · 17 filings

Report DateFiledAccession Number
2024-12-312025-04-150001437749-25-012050SEC ↗
2023-12-312024-03-290001437749-24-010029SEC ↗
2022-12-312023-03-300001437749-23-008658SEC ↗
2021-12-312022-03-310001437749-22-007873SEC ↗
2020-12-312021-03-310001437749-21-007838SEC ↗
2019-12-312020-03-300001437749-20-006563SEC ↗
2018-12-312019-04-010001437749-19-006239SEC ↗
2017-12-312018-04-020001437749-18-006069SEC ↗
2016-12-312017-03-310001437749-17-005780SEC ↗
2015-12-312016-04-060001564590-16-015942SEC ↗
2014-12-312015-04-010001564590-15-002296SEC ↗
2013-12-312014-03-130001564590-14-000701SEC ↗
2012-12-312013-03-130001193125-13-105429SEC ↗
2011-12-312012-03-130001193125-12-111926SEC ↗
2010-12-312011-03-300000950123-11-030644SEC ↗
2009-12-312010-03-100000950123-10-023053SEC ↗
2008-12-312009-03-170001362310-09-003961SEC ↗